- Home
- LPTH vs TOVX Comparison
LPTH vs TOVX Comparison
Compare LPTH & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- TOVX
- Stock Information
- Founded
- LPTH 1985
- TOVX 2001
- Country
- LPTH United States
- TOVX United States
- Employees
- LPTH N/A
- TOVX N/A
- Industry
- LPTH Semiconductors
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- TOVX Health Care
- Exchange
- LPTH Nasdaq
- TOVX Nasdaq
- Market Cap
- LPTH 388.2M
- TOVX 3.8M
- IPO Year
- LPTH 1996
- TOVX 2006
- Fundamental
- Price
- LPTH $9.68
- TOVX $0.86
- Analyst Decision
- LPTH Strong Buy
- TOVX Hold
- Analyst Count
- LPTH 3
- TOVX 1
- Target Price
- LPTH $6.83
- TOVX N/A
- AVG Volume (30 Days)
- LPTH 2.2M
- TOVX 10.0M
- Earning Date
- LPTH 11-06-2025
- TOVX 11-11-2025
- Dividend Yield
- LPTH N/A
- TOVX N/A
- EPS Growth
- LPTH N/A
- TOVX N/A
- EPS
- LPTH N/A
- TOVX N/A
- Revenue
- LPTH $37,202,630.00
- TOVX N/A
- Revenue This Year
- LPTH $61.33
- TOVX N/A
- Revenue Next Year
- LPTH $22.75
- TOVX N/A
- P/E Ratio
- LPTH N/A
- TOVX N/A
- Revenue Growth
- LPTH 17.26
- TOVX N/A
- 52 Week Low
- LPTH $1.40
- TOVX $0.37
- 52 Week High
- LPTH $10.69
- TOVX $2.64
- Technical
- Relative Strength Index (RSI)
- LPTH 63.19
- TOVX 81.63
- Support Level
- LPTH $7.90
- TOVX $0.43
- Resistance Level
- LPTH $10.59
- TOVX $0.51
- Average True Range (ATR)
- LPTH 1.09
- TOVX 0.06
- MACD
- LPTH 0.08
- TOVX 0.02
- Stochastic Oscillator
- LPTH 77.45
- TOVX 91.76
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.